does semaglutide cause heart problems Why Your Cardiologist May Prescribe (Wegovy) | News Cardiovascular outcomes of semaglutide and

Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides

10.1210/jcem.86.3.7330 15

There have been a few contenders over time, but the original is still one of the best-known references

In scientific studies, it is used to examine mechanisms of cell communication, matrix synthesis, and peptide-metal interactions

Oliai Araghi S et al

Meanwhile, Zepbound (tirzepatide) combines GIP and GLP-1 targeting, offering dual-action weight loss advantages